Variability between countries in cytokine responses to BCG vaccination: What impact might this have on protection?

Expert Review of Vaccines

Volumn 11, Issue 2, 2012, Pages 121-124

  Dockrell, Hazel M ^a   Smith, Steven G ^a   Lalor, Maeve K ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

BCG; biomarkers; immunological assays; infants; tuberculosis; vaccine efficacy

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; GAMMA INTERFERON;

BCG VACCINATION; CYTOKINE RESPONSE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALAWI; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; UNITED KINGDOM;

ADOLESCENT; BCG VACCINE; CYTOKINES; GREAT BRITAIN; HUMANS; INFANT; INTERFERON-GAMMA; MALAWI; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS; VACCINATION;

EID: 84863130048     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.186     Document Type: Review

References (18)

1. Kaufmann SH. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect. Dis. 11(8), 633-640 (2011).
2. Fine PE. Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 346(8986), 1339-1345 (1995).
3. Black GF, Weir RE, Floyd S et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: Two randomised controlled studies. Lancet 359(9315), 1393-1401 (2002). (Pubitemid 34442380)
4. Lalor MK, Ben-Smith A, Gorak-Stolinska P et al. Population differences in immune responses to bacille Calmette-Guérin vaccination in infancy. J. Infect. Dis. 199(6), 795-800 (2009).
5. Lalor MK, Floyd S, Gorak-Stolinska P et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J. Infect. Dis. 204 (7), 1075-1085 (2011).
6. Soares AP, Scriba TJ, Joseph S et al. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180(5), 3569-3577 (2008).
7. Hanekom WA, Dockrell HM, Ottenhoff TH et al. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med. 5(7), e145 (2008).
8. Elias D, Akuffo H, Britton S. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 99(5), 363-368 (2005). (Pubitemid 40361566)
9. Badell E, Nicolle F, Clark S et al. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine 27(1), 28-37 (2009).
10. Kagina BM, Abel B, Scriba TJ et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am. J. Respir. Crit. Care Med. 182(8), 1073-1079 (2010).
11. Joosten SA, Goeman JJ, Sutherland JS et al. Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun. doi:10.1038/gene.2011.64 (2011) (Epub ahead of print).
12. Berry MP, Graham CM, McNab FW et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466 (7309), 973-977 (2010).
13. Kagina BM, Abel B, Bowmaker M et al. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine 27(40), 5488-5495 (2009).
14. Burl S, Adetifa UJ, Cox M et al. Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J. Immunol. 185(4), 2620-2628 (2010).
15. Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M. A longitudinal study of BCG vaccination in early childhood: The development of innate and adaptive immune responses. PLoS One 5(11), e14066 (2010).
16. Djuardi Y, Wammes LJ, Supali T, Sartono E, Yazdanbakhsh M. Immunological footprint: The development of a child's immune system in environments rich in microorganisms and parasites. Parasitology 138(12), 1508-1518 (2011).
17. Colditz GA, Berkey CS, Mosteller F et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96(1 Pt 1), 29-35 (1995).
18. Salzman NH. Microbiota-immune system interaction: An uneasy alliance. Curr. Opin. Microbiol. 14(1), 99-105 (2011).